Related Experiment Video
Updated: Feb 22, 2026

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
Published on: March 20, 2020
Clinical Characteristics in Patients with Triple Negative Breast Cancer
Janet Yeh1, Jennifer Chun1, Shira Schwartz1
1Department of Surgery, New York University Langone Medical Center, New York, NY, USA.
Asian ancestry, prior breast cancer history, and BRCA1/BRCA2 mutations are linked to triple-negative breast cancer (TNBC). Understanding these risk factors is key for better TNBC prevention and treatment strategies.
Area of Science:
- Oncology
- Genetics
- Epidemiology
Background:
- Triple-negative breast cancer (TNBC) is an aggressive subtype with distinct clinical characteristics.
- Identifying genetic susceptibility and risk factors is crucial for targeted interventions.
- Understanding TNBC patient demographics and prior health history aids in risk stratification.
Purpose of the Study:
- To compare clinical features of TNBC versus non-TNBC patients.
- To investigate genetic susceptibility and risk factors associated with TNBC.
- To identify specific populations at higher risk for TNBC.
Main Methods:
- Retrospective analysis of an institutional database.
- Inclusion of patients diagnosed with invasive breast cancer between January 2010 and May 2016.
- Statistical comparison of demographic and clinical data between TNBC and non-TNBC groups.
Main Results:
- Out of 1964 patients, 190 (10%) had TNBC.
- TNBC was more prevalent in African American and Asian patients (p = 0.0003).
- BRCA1/BRCA2 mutations (p < 0.0001, p = 0.0007) and prior breast cancer history (p = 0.0003) were significantly associated with TNBC.
Conclusions:
- Asian ancestry, prior breast cancer, and BRCA1/BRCA2 mutations are positively associated with TNBC.
- Enhanced understanding of TNBC risk factors is needed for improved surveillance and prevention.
- Further research can inform the development of more effective TNBC treatments.
More Related Videos
07:45Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer
Published on: May 18, 2020
10:29Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
Published on: August 14, 2019